article thumbnail

Cosette Pharmaceuticals Acquires Mayne Pharma

The Dermatology Digest

Cosette Pharmaceuticals, Inc. By combining Cosettes strong portfolio with Mayne Pharmas proven commercial expertise, the combined company will be well positioned to further invest in innovation, portfolio expansion and better serve our patients. is acquiring Mayne Pharma.

article thumbnail

There Are So Many Skincare Lines– Is One Better Than Another?

Renee Rouleau

In theory, everyone can tap into these materials, but true innovation in skincare products is made through formulation and application. We all have access to the same ingredients, but it’s up to the chemist to find innovation in product formulation. I think of it like baking a cake. Skincare works in exactly the same way.

Skincare 195
article thumbnail

Touchdown: Novartis Named First-ever Corporate Pharmaceutical Partner of the NFL

The Dermatology Digest

Novartis is the official first-in-category corporate pharmaceutical partner of the National Football League (NFL). “We’re thrilled to welcome Novartis as our first-ever corporate partner across the pharmaceutical category,” says Senior Vice President, Sponsorship at the NFL Tracie Rodburg.

article thumbnail

The Power of Tech-Nature: How Sesha Fuses Biotech with Botanical Brilliance

Lipgloss and Aftershave

In an industry racing toward innovation and obsessed with results, theres a rare breed of skincare brand that manages to balance clinical-grade technology with the power of plants. This innovation became known as Permeation Enhancement Technology (P.E.T.) , and in 2002, it powered an FDA-approved pharmaceutical product.

article thumbnail

Smart fabric converts body energy into electricity 

Spa Executive

“This innovation brings us closer to practical applications for smart fabrics.” . “We have developed a fabric material with multifunctional sensing capabilities and self-powering potential,” said Yuning Li, a professor in the Department of Chemical Engineering.

article thumbnail

Dr. Vincent Wong Joins L+A as Medical Contributor

Lipgloss and Aftershave

He has authored a textbook on Aesthetic Medicine, published over 35 scientific papers, and serves as a Global Advisor for major pharmaceutical companies. As the creator of the world-renowned R-Technique, an innovative approach to dermal filler injections, he continuously pushes the boundaries of non-surgical aesthetics.

Medical 52
article thumbnail

JNJ Continues to Grow AD Pipeline With New Licensing Agreement

The Dermatology Digest

Johnson & Johnson has entered into an exclusive licensing agreement for the global development, manufacturing and commercialization of a STAT6 program for autoimmune and allergic diseases, including atopic dermatitis (AD), from Kaken Pharmaceutical. the venture capital organization of Johnson & Johnson.